Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Researchers improved a skin disease diagnosis model using online images, achieving up to 49.64% accuracy.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Some skin diseases and their treatments can negatively affect male fertility.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Gene variation affects prostate issues and hair loss.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Tamoxifen caused hair loss in a 52-year-old woman.

Skin health and diseases are closely linked to metabolic processes.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.